Amid these financial challenges, Eyenovia continues to advance its product development, nearing Phase III efficacy data readout for MicroPine, launching MydCombi and Clobetasol, and working on its Gen ...
Amid these financial challenges, Eyenovia continues to advance its product development, nearing Phase III efficacy data readout for MicroPine, launching MydCombi and Clobetasol, and working on its ...
This funding is earmarked for general corporate purposes, including the further development of its Optejet device and commercialization efforts for products like Mydcombi and clobetasol propionate.
This funding is earmarked for general corporate purposes, including the further development of its Optejet device and commercialization efforts for products like Mydcombi and clobetasol propionate.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback